Shares of Exelixis took a hit after the biotech reported that Helsinn Healthcare had shelved a late-stage trial for the anti-cancer therapy becatecarin (XL119). Helsinn had licensed the therapy from Exelixis, which in turn, had licensed it from Bristol-Myers Squibb. Helsinn halted enrollment after concluding that the therapy was proving less effective than chemotherapy. The drug was aimed at tumors of the biliary tract.
Kris – Thanks for the advice and I’m sorry to hear about your depression. Unfortunately, dad is pretty old-fashioned and doesn’t really share his feelings much in general, let alone go see a psychologist. The only one he would really talk to is mom. I’m actually more concerned about her b/c she is such a rock and I know that she needs to let some of the feelings/emotion out. She doesn’t want to with dad because it will just scare him and she doesn’t want to with me because we just end up crying together.
I wish she wasn’t such a technophobe and could IM/email people overseas but she just isn’t comfortable with computers. She really needs someone she can just call or who can call her.